Clinical Trial

To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment

Study acronym: VINOREAL
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study looks at how well oral vinorelbine works in treating advanced breast cancer. It looks at women who have already had this treatment or are currently having it.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-07-12; most recent amendment 2026-07-01.
Status change: Recruiting → Active, Not Recruiting 2026-07-01
Status change: Not Yet Recruiting → Recruiting 2025-07-21
Trial Details
NCT Number NCT06500494
Lead Sponsor Pierre Fabre Medicament
Conditions Advanced Breast Cancer
Enrollment 368 participants
Start Date 2024-09-10
Primary Completion 2028-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-02